BIOS 14. SynBio Revolution: Arvind Gupta - Partner @ Mayfield Fund / Founder @ IndieBio
Arvind Gupta is a Partner @ Mayfield Fund where he co-leads the Engineering Biology practice. He was the first investor in several breakout biology companies including Geltor, Prellis, Synthex, and Memphis Meats. Prior to joining Mayfield, Arvind was a founder of Indie Bio, the world’s leading biotech accelerator. At IndieBio, he was fundamental to the growth of the accelerator, building a $3.2B portfolio and investing in over 136 companies over five years. He is particularly passionate about conscious capitalism and continues to serve as a Venture Advisor at IndieBio.
Topics:
Career journey from design to biotech investing
Personal mission statements
Synthetic biology guiding the biotech revolution
Conscious capital and engineering biology
What to expect for the future of “tech bio”
How VC will evolve with new capital structures in biotech
Advice for life sciences founders
Thank you for listening!
BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.